文献速递运动医学关节外科

单纯前交叉韧带重建与联合前交叉韧带及前外侧韧带重建比较:功能结局、重返运动与生存率——比较研究的更新Meta分析

Isolated ACL Reconstruction Versus Combined ACL and Anterolateral Ligament Reconstruction: Functional Outcomes, Return to Sport, and Survivorship: An Updated Meta-analysis of Comparative Studies.
PubMed 文献 · Am J Sports Med · 2025-01-04

该Meta分析纳入16项比较研究共2329例患者,比较联合前交叉韧带(ACL)及前外侧韧带(ALL)重建与单纯ACL重建。两组Tegner、Lysholm和IKDC评分无显著差异;联合重建组移植失败率更低(OR 0.37)、重返运动率更高(OR 1.41)、生存率更高(OR 2.94),单纯ACL重建组术后膝关节松弛度显著更大。

要点

  • 联合ACL及ALL重建与单纯ACL重建的功能评分(Tegner、Lysholm、IKDC)无显著差异。
  • 单纯ACL重建组术后膝关节松弛度显著大于联合重建组(均差-0.44;95%CI -0.85至-0.04;P=0.03)。
  • 联合重建组移植失败率更低(OR 0.37;95%CI 0.18-0.77;P=0.008),重返运动率(OR 1.41)和生存率(OR 2.94)更高。

核心结论

  • 与单纯ACL重建相比,联合ACL及ALL重建功能结局相当,但残余膝关节松弛度显著更小、移植失败率更低。
  • 接受联合ACL及ALL重建的患者重返运动率和生存率也更高。

研究设计与样本

  • Meta分析,证据等级4级;检索PubMed/MEDLINE、Scopus和Cochrane Central数据库,共纳入16项研究。
  • 共鉴定2329例患者,其中1116例接受联合ACL及ALL重建,1213例接受单纯ACL重建。
  • 联合ACL及ALL重建组平均年龄25.4±7.2岁,单纯ACL重建组平均年龄26.5±7.8岁。
  • 联合ACL及ALL重建组平均随访40.3±21.4个月,单纯ACL重建组平均随访42.5±21.6个月。
  • 采用随机效应和固定效应模型对合并均差和比值比进行Meta分析。

主要发现

  • 两组Tegner活动量表评分(P=0.16)、Lysholm膝关节评分(P=0.13)和IKDC评分(P=0.83)相当。
  • 单纯ACL重建组术后膝关节松弛度显著大于联合ACL及ALL重建组(均差-0.44;95%CI -0.85至-0.04;P=0.03)。
  • 联合ACL及ALL重建组移植失败率显著低于单纯ACL重建组(OR 0.37;95%CI 0.18-0.77;P=0.008)。
  • 联合ACL及ALL重建组重返运动率显著高于单纯ACL重建组(OR 1.41;95%CI 1.11-1.80;P=0.005)。
  • 联合ACL及ALL重建组生存率显著高于单纯ACL重建组(OR 2.94;95%CI 1.97-4.37;P<0.001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Failure, persistent knee instability, and reinjury rates after anterior cruciate ligament (ACL) reconstruction are still concerns. Biomechanical investigations have highlighted the role of the anterolateral ligament (ALL) as a crucial knee stabilizer, and clinical outcomes after combined ACL and ALL reconstruction appear to indicate the success of the procedure. PURPOSE: To compare the functional outcomes, return-to-sport (RTS) rate, and complications between combined ACL and ALL reconstruction and isolated ACL reconstruction. STUDY DESIGN: Meta-analysis; Level of evidence, 4. METHODS: The PubMed/MEDLINE, Scopus, and Cochrane Central databases were used to search keywords, and a total of 16 studies were included. The data extracted for quantitative analysis included the Tegner activity scale score, Lysholm knee score, International Knee Documentation Committee (IKDC) score, laxity measured using the KT-1000 knee arthrometer, number and types of complications, RTS rate, and survival rate. Random- and fixed-effects models were used for the meta-analysis of pooled mean differences and odds ratios. RESULTS: A total of 2329 patients were identified, 1116 of whom underwent combined ACL and ALL reconstruction and 1213 of whom underwent isolated ACL reconstruction. The mean ages were 25.4 ± 7.2 years and 26.5 ± 7.8 years for the combined ACL and ALL reconstruction and isolated ACL reconstruction groups, respectively. The mean follow-ups were 40.3 ± 21.4 months and 42.5 ± 21.6 months, respectively. Comparable Tegner activity scale (P = .16), Lysholm knee (P = .13), and IKDC (P = .83) scores were found between groups. Significantly greater postoperative knee laxity was found in the isolated ACL reconstruction group (mean difference, -0.44; 95% CI, -0.85 to -0.04; P = .03). The combined ACL and ALL reconstruction group showed a significantly lower rate of graft failure (odds ratio [OR], 0.37; 95% CI, 0.18-0.77; P = .008), a higher RTS rate (OR, 1.41; 95% CI, 1.11-1.80; P = .005), and a higher survival rate (OR, 2.94; 95% CI, 1.97-4.37; P < .001). CONCLUSION: Compared with isolated ACL reconstruction, combined ACL and ALL reconstruction yielded comparable functional outcomes but significantly less residual knee laxity and a lower graft failure rate. Patients who underwent combined ACL and ALL reconstruction also had higher RTS and survival rates.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Mercurio M, Cofano E, Gasparini G, et al. Isolated ACL Reconstruction Versus Combined ACL and Anterolateral Ligament Reconstruction: Functional Outcomes, Return to Sport, and Survivorship: An Updated Meta-analysis of Comparative Studies. Am J Sports Med. 2025. PMID: 39754418. doi:10.1177/03635465241251467

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。